Research
Aspirin does not prevent recurrence after treatment for colorectal cancer liver metastases
The Brief
- Aspirin did not prevent recurrence after treatment for colorectal cancer liver metastases, according to Medical Xpress.
- Colorectal cancer is one of the most common cancers in Norway, which has one of the highest incidence rates in the world.
Why it matters
Patients and clinicians should not expect aspirin to lower the risk of recurrence after treatment for colorectal cancer that has spread to the liver.
Who’s affected
- Patients with colorectal cancer liver metastases
- Clinicians treating colorectal cancer
- #colorectal cancer
- #liver metastases
- #aspirin
- #oncology
- #recurrence
Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world.